| Amdahl Hearing | |
|
411 Stageline Rd # 290, Hudson, WI 54016-7848 | |
| (715) 531-6710 | |
| Not Available |
| Full Name | Amdahl Hearing |
|---|---|
| Type | Facility |
| Speciality | Audiologist |
| Location | 411 Stageline Rd # 290, Hudson, Wisconsin |
| Accepts Medicare Assignments | Medicare enrolled and accepts medicare insurance. Providers at this facility may prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1417484239 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 231H00000X | Audiologist | (* (Not Available)) | Primary |
| Provider Name | Raena S Deperry |
|---|---|
| Provider Type | Practitioner - Qualified Audiologist |
| Provider Identifiers | NPI Number: 1114018447 PECOS PAC ID: 5092896233 Enrollment ID: I20080114000841 |
News Archive
TechniScan, Inc.'s unique whole breast ultrasound technology, which provides a comfortable, radiation-free method for assessment of breast lesions was part of a scientific presentation at the National Consortium of Breast Centers (NCBC) conference in Las Vegas last week.
A statistical model accounting for dozens of different genes in combination-and the interactions between them-is an important step forward in understanding the genetic factors affecting the risk of Crohn's disease (CD), reports a study in Inflammatory Bowel Diseases, official journal of the Crohn's & Colitis Foundation of America (CCFA). The journal is published by Lippincott Williams & Wilkins, a part of Wolters Kluwer Health.
A study led by researchers at The Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC - James) has identified an abnormal metabolic pathway that drives cancer-cell growth in a particular glioblastoma subtype. The finding might lead to new therapies for a subset of patients with glioblastoma, the most common and lethal form of brain cancer.
A research team led by Children's National Hospital faculty was able to "rescue" a pre-clinical model of fetal alcohol spectrum disorder in juvenile models, reversing motor skill deficits with the help of a novel drug derived from scorpion venom.
› Verified 5 days ago
| Provider Name | Kari Nicole Hancher |
|---|---|
| Provider Type | Practitioner - Qualified Audiologist |
| Provider Identifiers | NPI Number: 1932766441 PECOS PAC ID: 6103157383 Enrollment ID: I20191021000793 |
News Archive
TechniScan, Inc.'s unique whole breast ultrasound technology, which provides a comfortable, radiation-free method for assessment of breast lesions was part of a scientific presentation at the National Consortium of Breast Centers (NCBC) conference in Las Vegas last week.
A statistical model accounting for dozens of different genes in combination-and the interactions between them-is an important step forward in understanding the genetic factors affecting the risk of Crohn's disease (CD), reports a study in Inflammatory Bowel Diseases, official journal of the Crohn's & Colitis Foundation of America (CCFA). The journal is published by Lippincott Williams & Wilkins, a part of Wolters Kluwer Health.
A study led by researchers at The Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC - James) has identified an abnormal metabolic pathway that drives cancer-cell growth in a particular glioblastoma subtype. The finding might lead to new therapies for a subset of patients with glioblastoma, the most common and lethal form of brain cancer.
A research team led by Children's National Hospital faculty was able to "rescue" a pre-clinical model of fetal alcohol spectrum disorder in juvenile models, reversing motor skill deficits with the help of a novel drug derived from scorpion venom.
› Verified 5 days ago
| Provider Name | Daniel Dibenedetto |
|---|---|
| Provider Type | Practitioner - Qualified Audiologist |
| Provider Identifiers | NPI Number: 1326778416 PECOS PAC ID: 3870973027 Enrollment ID: I20220705003020 |
News Archive
TechniScan, Inc.'s unique whole breast ultrasound technology, which provides a comfortable, radiation-free method for assessment of breast lesions was part of a scientific presentation at the National Consortium of Breast Centers (NCBC) conference in Las Vegas last week.
A statistical model accounting for dozens of different genes in combination-and the interactions between them-is an important step forward in understanding the genetic factors affecting the risk of Crohn's disease (CD), reports a study in Inflammatory Bowel Diseases, official journal of the Crohn's & Colitis Foundation of America (CCFA). The journal is published by Lippincott Williams & Wilkins, a part of Wolters Kluwer Health.
A study led by researchers at The Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC - James) has identified an abnormal metabolic pathway that drives cancer-cell growth in a particular glioblastoma subtype. The finding might lead to new therapies for a subset of patients with glioblastoma, the most common and lethal form of brain cancer.
A research team led by Children's National Hospital faculty was able to "rescue" a pre-clinical model of fetal alcohol spectrum disorder in juvenile models, reversing motor skill deficits with the help of a novel drug derived from scorpion venom.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Amdahl Hearing 2848 2nd St S, Suite 185, Saint Cloud, MN 56301-4594 Ph: (320) 252-0094 | Amdahl Hearing 411 Stageline Rd # 290, Hudson, WI 54016-7848 Ph: (715) 531-6710 |
News Archive
TechniScan, Inc.'s unique whole breast ultrasound technology, which provides a comfortable, radiation-free method for assessment of breast lesions was part of a scientific presentation at the National Consortium of Breast Centers (NCBC) conference in Las Vegas last week.
A statistical model accounting for dozens of different genes in combination-and the interactions between them-is an important step forward in understanding the genetic factors affecting the risk of Crohn's disease (CD), reports a study in Inflammatory Bowel Diseases, official journal of the Crohn's & Colitis Foundation of America (CCFA). The journal is published by Lippincott Williams & Wilkins, a part of Wolters Kluwer Health.
A study led by researchers at The Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC - James) has identified an abnormal metabolic pathway that drives cancer-cell growth in a particular glioblastoma subtype. The finding might lead to new therapies for a subset of patients with glioblastoma, the most common and lethal form of brain cancer.
A research team led by Children's National Hospital faculty was able to "rescue" a pre-clinical model of fetal alcohol spectrum disorder in juvenile models, reversing motor skill deficits with the help of a novel drug derived from scorpion venom.
› Verified 5 days ago
Dr. Raena Sue Deperry, AUD Audiologist Medicare: Accepting Medicare Assignments Practice Location: 401 Stageline Rd, Ste. 6, Hudson, WI 54016 Phone: 715-531-6710 Fax: 715-531-6711 | |
Mrs. Deirdre Ann Worrell, MS Audiologist Medicare: Not Enrolled in Medicare Practice Location: 1516 North Ridge Dr, Hudson, WI 54016 Phone: 715-386-1760 | |
Mrs. Michele Anne Drevnick, M.S., F-AAA Audiologist Medicare: Not Enrolled in Medicare Practice Location: 401 Stageline Rd, Suite 6, Hudson, WI 54016 Phone: 715-531-6710 Fax: 715-531-6711 | |
Hudson Hearing & Speech Clinic Inc Audiologist Medicare: Not Enrolled in Medicare Practice Location: 401 Stageline Rd, Suite 6, Hudson, WI 54016 Phone: 715-531-6710 Fax: 715-531-6711 | |
Dr. Kari Nicole Hancher, AUD Audiologist Medicare: Accepting Medicare Assignments Practice Location: 411 Stageline Rd, Hudson, WI 54016 Phone: 715-531-6710 |